Skip to main content
OpenTrials

Clinical trial condition

Stage II Breast Cancer

Explore clinical trials studying Stage II Breast Cancer. Study availability and eligibility vary by location and protocol.

85 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Stage II Breast Cancer trial results

Active, Not Recruiting

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

NCT02445391

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +16 more
Locations
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 1024 locations
View Trial Details
Active, Not Recruiting

Researching the Effect of Exercise on Cancer

NCT04589468

Conditions
Behavior, Breast Cancer, Breast Diseases, +34 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Natera, Inc. (Data or Specimen Analysis Only) San Carlos, California, United States
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
View Trial Details
Active, Not Recruiting

Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy

NCT01901094

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Southern Cancer Center PC-Daphne Daphne, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Southern Cancer Center PC-Mobile Mobile, Alabama, United States
  • Southern Cancer Center PC-Providence Mobile, Alabama, United States
View all 1246 locations
View Trial Details
Active, Not Recruiting

Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca

NCT02957968

Conditions
Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +17 more
Locations
  • St. Elizabeth Healthcare Edgewood, Kentucky, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • University of Virginia Charlottesville, Virginia, United States
  • Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States
View Trial Details
Active, Not Recruiting

Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery

NCT01953588

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +20 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 860 locations
View Trial Details
Active, Not Recruiting

Acupuncture Pilot Study for Cancer-related Cognitive Function

NCT04007770

Conditions
Breast Diseases, Breast Neoplasms, Colonic Diseases, +33 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Active, Not Recruiting

Niraparib + Dostarlimab In BRCA Mutated Breast Cancer

NCT04584255

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
Locations
  • Yale University Cancer Center New Haven, Connecticut, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA

NCT02326974

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Tennessee Oncology/Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details

Related conditions